[144] TAT TECHNOLOGIES LTD SEC Filing
Rhea-AI Filing Summary
TAT Technologies Ltd. filed a Form 144 notifying the proposed sale of 7,650 ordinary shares through Oppenheimer & Co. on 09/17/2025, with an aggregate market value of $296,820.00. The shares were acquired under an Employee Stock Option Plan on 05/13/2018 and will be paid in cash upon exercise. The filing lists 10,940,358 shares outstanding for the class, and discloses a prior sale by the same person of 7,311 shares on 08/14/2025 for $263,196.00. The filer certifies they are not aware of undisclosed material adverse information.
Positive
- None.
Negative
- None.
Insights
TL;DR: Insider plans a modest sale of vested options; size relative to float is immaterial and likely routine liquidity.
The Form 144 shows an intended sale of 7,650 shares valued at $296,820, acquired under an employee stock option plan in 2018 and to be sold through a registered broker on 09/17/2025. With 10,940,358 shares outstanding, the transaction represents roughly 0.07% of the class, indicating this is a minor disposal by an insider rather than a material change in ownership. The filing also discloses a recent sale of 7,311 shares on 08/14/2025, suggesting ongoing incremental dispositions of vested shares.
TL;DR: Disclosure complies with Rule 144 requirements; no apparent governance red flags in the filing itself.
The notice provides the required details: acquisition date, nature of acquisition (employee stock option), payment method (cash upon exercise), broker identity, and recent sales history by the same person. The signer affirms no undisclosed material adverse information. The document does not show any unusual lock-up, related-party transfer, or exception to standard Rule 144 procedures. Based solely on this filing, there are no immediate governance concerns.